Jay Glenn Wohlgemuth

Chief Executive Officer at Pacegenix.

Earliest Form D on file: Mar 2026

Filed Mar 26, 2026

Pacegenix

Prodrugs for atrial fibrillation and fast heart rates

Biotech, Cambridge MA

Signed as Chief Executive Officer

$22.5M

sold of $22.5M offered

Network

At Pacegenix

3 people